We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $3.37B
This Fund
S&P 500
This Quarter Est. Return
+11.07%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.1B
AUM Growth
-$1.95B
Cap. Flow
-$2.01B
Cap. Flow %
-182.11%
Top 10 Hldgs %
55.43%
Holding
359
New
34
Increased
188
Reduced
93
Closed
36

Top Buys

Rank Stock Value
1
STAA icon
STAAR Surgical
STAA
+$38.7M
2
SE icon
Sea Limited
SE
+$29.1M
3
MELI icon
Mercado Libre
MELI
+$27M
4
META icon
Meta Platforms (Facebook)
META
+$19.3M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$17.2M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$1.32B
2
JD icon
JD.com
JD
+$301M
3
BIDU icon
Baidu
BIDU
+$279M
4
NTES icon
NetEase
NTES
+$202M
5
TCOM icon
Trip.com Group
TCOM
+$77.3M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 35.58%
2 Technology 17.59%
3 Communication Services 16.9%
4 Healthcare 11.23%
5 Real Estate 6.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALKS icon
151
Alkermes
ALKS
$8.62B
$475K 0.04%
15,946
+4,943
+45% +$142K
SRPT icon
152
Sarepta Therapeutics
SRPT
$1.78B
$475K 0.04%
6,333
+2,887
+84% +$212K
BBIO icon
153
BridgeBio Pharma
BBIO
$15.8B
$472K 0.04%
51,948
+20,684
+66% +$173K
BCRX icon
154
BioCryst Pharmaceuticals
BCRX
$2.32B
$470K 0.04%
44,408
+27,767
+167% +$286K
PANW icon
155
Palo Alto Networks
PANW
$284B
$470K 0.04%
5,706
+144
+3% +$12.8K
UTHR icon
156
United Therapeutics
UTHR
$22.5B
$468K 0.04%
1,985
+434
+28% +$88.2K
IONS icon
157
Ionis Pharmaceuticals
IONS
$8.75B
$466K 0.04%
12,597
+4,263
+51% +$161K
EDIT icon
158
Editas Medicine
EDIT
$442M
$465K 0.04%
39,341
+21,529
+121% +$288K
BPMC
159
DELISTED
Blueprint Medicines
BPMC
$460K 0.04%
9,109
+4,411
+94% +$258K
EBS icon
160
Emergent Biosolutions
EBS
$397M
$454K 0.04%
14,640
+7,286
+99% +$249K
NTRA icon
161
Natera
NTRA
$37.6B
$454K 0.04%
12,803
+5,921
+86% +$219K
VCYT icon
162
Veracyte
VCYT
$4.57B
$454K 0.04%
22,816
+11,540
+102% +$233K
NBIX icon
163
Neurocrine Biosciences
NBIX
$17.4B
$453K 0.04%
4,643
+1,638
+55% +$151K
RCUS icon
164
Arcus Biosciences
RCUS
$3.54B
$450K 0.04%
17,775
+9,670
+119% +$237K
XEL icon
165
Xcel Energy
XEL
$49.1B
$445K 0.04%
6,283
+163
+3% +$11.9K
BHVN
166
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$443K 0.04%
3,039
+780
+35% +$99.6K
IDXX icon
167
Idexx Laboratories
IDXX
$44.5B
$442K 0.04%
1,259
+69
+6% +$28.1K
HALO icon
168
Halozyme
HALO
$9.14B
$440K 0.04%
10,000
+2,274
+29% +$98.3K
ROP icon
169
Roper Technologies
ROP
$36.6B
$440K 0.04%
+1,115
New +$485K
BAC icon
170
Bank of America
BAC
$424B
$438K 0.04%
14,078
+30
+0.2% +$1.08K
DXCM icon
171
DexCom
DXCM
$29.2B
$438K 0.04%
5,872
+360
+7% +$32.9K
CYTK icon
172
Cytokinetics
CYTK
$10.7B
$436K 0.04%
11,086
+3,932
+55% +$158K
CCXI
173
DELISTED
ChemoCentryx, Inc.
CCXI
$433K 0.04%
17,480
+6,171
+55% +$136K
IRWD icon
174
Ironwood Pharmaceuticals
IRWD
$634M
$430K 0.04%
37,265
+14,279
+62% +$168K
CTAS icon
175
Cintas
CTAS
$80.7B
$428K 0.04%
4,588
– –
5 6
7
8 9

Similar funds

VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
TAM
Troy Asset Management London, United Kingdom $3.35B AUM 11.7% 1-Year Est. Return
CS
CapitalatWork SA Auderghem $3.35B AUM
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
QCG
Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return

E Fund Management's Q2 2022 Portfolio in Review

As of Q2 2022, E Fund Management held 359 positions worth $1.1B, down 64% from $3.06B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

E Fund Management withdrew a net $2.01B in Q2 2022, closing 36 positions and reducing 93 holdings. Its most notable exit was Alibaba, an estimated $1.32B position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 36% of assets, down from 63% a quarter earlier, followed by Technology and Communication Services.

Against the trend, E Fund Management opened a new position in Sea Limited worth $22.9M.

  • E Fund Management's largest Q2 2022 buy was Sea Limited: 342,000 shares worth $22.9M.
  • E Fund Management added most to STAAR Surgical in Q2 2022, an estimated $38.7M increase.
  • E Fund Management's biggest Q2 2022 reduction was JD.com, cutting an estimated $301M.
  • E Fund Management fully exited Alibaba in Q2 2022, selling an estimated $1.32B.
  • E Fund Management's ten largest holdings make up 55% of its $1.1B portfolio in Q2 2022.
  • E Fund Management opened 34 new positions and closed 36 in Q2 2022.
  • E Fund Management's portfolio value fell 64% quarter-over-quarter to $1.1B.

Based on E Fund Management's 13F filing for Q2 2022, filed 15 Aug 2022.